Blavatnik Biomedical Accelerator
FUSION: A unique event for innovative leaders
Harvard’s FUSION symposium integrates perspectives from science and business to explore the promise of an emerging field. This annual, invite-only event brings together entrepreneurs, scientists, business leaders, investors, and innovators for a half-day of exploration and networking. The FUSION symposium is jointly hosted by the Blavatnik Biomedical Accelerator (a program of Harvard University's Office of Technology Development) and by the Blavatnik Fellowship in Life Science Entrepreneurship at Harvard Business School.
The fourth FUSION symposium will address The Science and Business of Cell and Gene Therapy. For more information, contact firstname.lastname@example.org.
FUSION 2019: The Science and Business of Aging
FUSION 2019 Recap
While the medical, scientific, and economic challenges related to aging are immense, many scientific and business leaders are engaged and are focused on practical, scalable, innovative solutions. Some solutions already exist, and others aren’t far off. Read the FUSION 2019 Summary
Sachin H. Jain '02, MD'06, MBA '07
President and Chief Executive Officer, CareMore Health System
Richard J. Hodes, MD '69
Director of the National Institute on Aging at the National Institutes of Health
George Church, PhD '84
Robert Winthrop Professor of Genetics, Blavatnik Institute at Harvard Medical School
Elli Kaplan, MBA '05
Co-founder and Chief Executive Officer, Neurotrack
Nir Barzilai, MD
Professor of Medicine and of Genetics, Albert Einstein College of Medicine; Director of the Institute for Aging Research, Director of the Paul F. Glenn Center for the Biology of Human Aging Research, and Director of the NIH Nathan Shock Centers of Excellence in the Basic Biology of Aging
In many ways, this has proven to be more spectacular than anything that we might have imagined.
Dean, Harvard Business School
Lawrence S. Bacow
President of Harvard University
Dean of Harvard Business School
Michelle A. Williams
Dean of Harvard T.H. Chan School of Public Health
George Q. Daley
Dean of Harvard Medical School
Len Blavatnik MBA '89
Founder and Chairman, Access Industries
Faculty Chair, Blavatnik Fellowship in Life Science Entrepreneurship; Partner, Atlas Venture
Senior Associate Provost and Chief Technology Development Officer
Director, HBS Health Care Initiative
Global population aging is one of the greatest public health challenges of our time. Aging populations will affect the workforce. They will affect families and education and healthcare policies. They will strain healthcare systems, especially those in low-income communities and countries.
Dean, Harvard T.H. Chan School of Public Health
Lending insights to action for the aging world
The inevitable infirmities of aging may not be so certain after all. Though few products on the market today can help turn back the hands of time, that may soon change.